Efficacy of Prophylactic Hemoclips in Prevention of Delayed Post-Polypectomy Bleeding in Patients With Large Colonic Polyps.


Journal

Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630

Informations de publication

Date de publication:
10 2019
Historique:
received: 25 02 2019
revised: 01 05 2019
accepted: 03 05 2019
pubmed: 4 6 2019
medline: 23 10 2019
entrez: 4 6 2019
Statut: ppublish

Résumé

The efficacy of prophylactic placement of hemoclips to prevent delayed bleeding after removal of large colonic polyps has not been established. We conducted a randomized equivalence study to determine whether prophylactic placement of hemoclips affects incidence of delayed post-polypectomy bleeding (PPB). During elective colonoscopy performed at 4 Veterans Affairs Medical Centers, 1098 patients who had polyps ≥1 cm removed were randomly assigned to groups that received prophylactic hemoclips (n = 547) or no hemoclips (n = 551), from September 2011 through September 2018. Data on PPB (rectal bleeding resulting in hemoglobin decreases ≥2 g/dL, hemodynamic instability, colonoscopy, angiography, or surgery) within 30 days of colonoscopy (called delayed PPB) were collected during telephone interviews or hospital visits 7 and 30 days after colonoscopy. The primary outcome was the incidence of important post-polypectomy bleeding. Twelve patients in the hemoclip group (2.3%) and 15 patients in the no hemoclip group (2.9%) had important delayed PPB. There were no deaths, and no patients in either group required angiography or surgery. In intention-to-treat analysis, two 1-sided test's lower and upper confidence interval limits were -2.07 and 1.01, indicating that the data approached but did not meet equivalence criteria. On multiple logistic regression analysis, significant predictors of PPB included use of warfarin with bridging, thienopyridines, polyp size, and polyp location, but hemoclip placement did not associate with important delayed PPB. In a randomized trial, we found that prophylactic placement of hemoclips after removal of large colon polyps does not affect the proportion of important delayed PPB events, compared with no hemoclip placement. These findings call into question the widespread, expensive practice of routinely placing prophylactic hemoclips after polypectomy. ClinicalTrials.gov ID: NCT01647581.

Sections du résumé

BACKGROUND & AIMS
The efficacy of prophylactic placement of hemoclips to prevent delayed bleeding after removal of large colonic polyps has not been established. We conducted a randomized equivalence study to determine whether prophylactic placement of hemoclips affects incidence of delayed post-polypectomy bleeding (PPB).
METHODS
During elective colonoscopy performed at 4 Veterans Affairs Medical Centers, 1098 patients who had polyps ≥1 cm removed were randomly assigned to groups that received prophylactic hemoclips (n = 547) or no hemoclips (n = 551), from September 2011 through September 2018. Data on PPB (rectal bleeding resulting in hemoglobin decreases ≥2 g/dL, hemodynamic instability, colonoscopy, angiography, or surgery) within 30 days of colonoscopy (called delayed PPB) were collected during telephone interviews or hospital visits 7 and 30 days after colonoscopy. The primary outcome was the incidence of important post-polypectomy bleeding.
RESULTS
Twelve patients in the hemoclip group (2.3%) and 15 patients in the no hemoclip group (2.9%) had important delayed PPB. There were no deaths, and no patients in either group required angiography or surgery. In intention-to-treat analysis, two 1-sided test's lower and upper confidence interval limits were -2.07 and 1.01, indicating that the data approached but did not meet equivalence criteria. On multiple logistic regression analysis, significant predictors of PPB included use of warfarin with bridging, thienopyridines, polyp size, and polyp location, but hemoclip placement did not associate with important delayed PPB.
CONCLUSIONS
In a randomized trial, we found that prophylactic placement of hemoclips after removal of large colon polyps does not affect the proportion of important delayed PPB events, compared with no hemoclip placement. These findings call into question the widespread, expensive practice of routinely placing prophylactic hemoclips after polypectomy. ClinicalTrials.gov ID: NCT01647581.

Identifiants

pubmed: 31158369
pii: S0016-5085(19)40859-7
doi: 10.1053/j.gastro.2019.05.003
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01647581']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

967-976.e1

Subventions

Organisme : CSRD VA
ID : I01 CX000815
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Auteurs

Linda A Feagins (LA)

Department of Medicine, Veterans Affairs North Texas Healthcare System, Dallas, Texas; Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: linda.feagins@austin.utexas.edu.

Andrew D Smith (AD)

Department of Medicine, Veterans Affairs North Texas Healthcare System, Dallas, Texas.

Daniel Kim (D)

Department of Medicine, Veterans Affairs North Texas Healthcare System, Dallas, Texas.

Akeel Halai (A)

Department of Medicine, Veterans Affairs North Texas Healthcare System, Dallas, Texas.

Suneetha Duttala (S)

Department of Medicine, Veterans Affairs North Texas Healthcare System, Dallas, Texas.

Benjamin Chebaa (B)

Department of Medicine, Veterans Affairs North Texas Healthcare System, Dallas, Texas.

Tisha Lunsford (T)

Department of Medicine, South Texas Veterans Healthcare System, San Antonio, Texas; Department of Medicine, University of Texas San Antonio Health Sciences Center, San Antonio, Texas.

John Vizuete (J)

Department of Medicine, South Texas Veterans Healthcare System, San Antonio, Texas; Department of Medicine, University of Texas San Antonio Health Sciences Center, San Antonio, Texas.

Miriam Mara (M)

Department of Medicine, South Texas Veterans Healthcare System, San Antonio, Texas.

Ranjan Mascarenhas (R)

Department of Medicine, Central Texas Veterans Healthcare System, Austin Outpatient Clinic, Austin, Texas; Department of Medicine, Dell Medical School, The University of Texas at Austin, Austin, Texas.

Rabia Meghani (R)

Department of Medicine, Central Texas Veterans Healthcare System, Austin Outpatient Clinic, Austin, Texas.

Leon Kundrotas (L)

Department of Medicine, South Texas Veterans Healthcare System, San Antonio, Texas; Department of Medicine, University of Texas San Antonio Health Sciences Center, San Antonio, Texas.

Kerry B Dunbar (KB)

Department of Medicine, Veterans Affairs North Texas Healthcare System, Dallas, Texas; Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.

Daisha J Cipher (DJ)

The College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, Texas.

William V Harford (WV)

Department of Medicine, Veterans Affairs North Texas Healthcare System, Dallas, Texas; Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.

Stuart J Spechler (SJ)

Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH